Keudell Morrison Wealth Management Takes $2.15 Million Position in Stryker Corporation $SYK

Keudell Morrison Wealth Management acquired a new stake in Stryker Corporation (NYSE:SYK) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 6,105 shares of the medical technology company’s stock, valued at approximately $2,146,000.

Several other hedge funds also recently modified their holdings of SYK. Brighton Jones LLC grew its holdings in Stryker by 15.4% during the fourth quarter. Brighton Jones LLC now owns 4,564 shares of the medical technology company’s stock worth $1,643,000 after purchasing an additional 609 shares during the period. Schnieders Capital Management LLC. bought a new position in Stryker during the second quarter worth about $205,000. Marshall Wace LLP grew its holdings in Stryker by 107.9% during the second quarter. Marshall Wace LLP now owns 5,700 shares of the medical technology company’s stock worth $2,255,000 after purchasing an additional 77,831 shares during the period. Nebula Research & Development LLC bought a new position in Stryker during the second quarter worth about $219,000. Finally, HUB Investment Partners LLC bought a new position in Stryker during the second quarter worth about $253,000. Institutional investors own 77.09% of the company’s stock.

Stryker Trading Down 2.5%

Shares of NYSE:SYK opened at $313.48 on Friday. Stryker Corporation has a 12-month low of $281.00 and a 12-month high of $404.87. The stock has a market cap of $120.17 billion, a PE ratio of 36.28, a P/E/G ratio of 2.03 and a beta of 0.80. The business has a 50 day moving average of $325.81 and a 200-day moving average of $350.06. The company has a quick ratio of 1.25, a current ratio of 2.11 and a debt-to-equity ratio of 0.62.

Stryker (NYSE:SYK) last issued its quarterly earnings data on Thursday, April 30th. The medical technology company reported $2.60 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.98 by ($0.38). Stryker had a return on equity of 23.42% and a net margin of 13.20%.The firm had revenue of $6.02 billion for the quarter, compared to the consensus estimate of $6.34 billion. During the same quarter in the prior year, the firm earned $2.84 EPS. The company’s revenue was up 2.6% on a year-over-year basis. Stryker has set its FY 2026 guidance at 14.900-15.100 EPS. As a group, equities research analysts forecast that Stryker Corporation will post 14.98 earnings per share for the current year.

Stryker Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Tuesday, June 30th will be issued a dividend of $0.88 per share. This represents a $3.52 dividend on an annualized basis and a dividend yield of 1.1%. The ex-dividend date is Tuesday, June 30th. Stryker’s payout ratio is currently 40.74%.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on the company. BTIG Research reduced their price target on Stryker from $397.00 to $379.00 and set a “buy” rating for the company in a report on Friday, May 1st. Jefferies Financial Group reiterated a “buy” rating and set a $465.00 price target on shares of Stryker in a report on Wednesday, March 4th. William Blair reissued an “outperform” rating on shares of Stryker in a report on Thursday, March 5th. Needham & Company LLC lowered their price target on shares of Stryker from $454.00 to $418.00 and set a “buy” rating on the stock in a report on Friday, May 1st. Finally, Canaccord Genuity Group reduced their price objective on Stryker from $435.00 to $400.00 and set a “buy” rating for the company in a report on Friday, May 1st. Sixteen research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $395.48.

Insider Activity

In other news, VP M Kathryn Fink sold 3,500 shares of the business’s stock in a transaction that occurred on Monday, May 11th. The stock was sold at an average price of $283.45, for a total transaction of $992,075.00. Following the completion of the sale, the vice president owned 177 shares in the company, valued at $50,170.65. The trade was a 95.19% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. 4.60% of the stock is currently owned by corporate insiders.

Stryker Company Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.